OASIS – FDA approved study design to test BlueWind Medical’s RENOVA iStim system, a batt

June 14, 2018 (Flag Day)

OASIS – Overactive Bladder Stimulation System study will trial 250 patients.  Enrollment begins in 2019 and will test efficacy of tibial nerve stim for treatment refractory OAB.

MDMagazine

#Trial #iStim #tibialnerve #OveractiveBladder #FDA #OAB #Nervestimulation #RENOVA